Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oncolytic Virotherapy | 33 | 2024 | 516 | 6.870 |
Why?
|
Glioblastoma | 61 | 2024 | 3483 | 4.830 |
Why?
|
Oncolytic Viruses | 22 | 2024 | 344 | 4.290 |
Why?
|
Brain Neoplasms | 84 | 2024 | 9032 | 4.220 |
Why?
|
Simplexvirus | 29 | 2023 | 803 | 3.610 |
Why?
|
Meningioma | 23 | 2024 | 1218 | 3.320 |
Why?
|
Meningeal Neoplasms | 23 | 2024 | 1248 | 2.920 |
Why?
|
Glioma | 38 | 2024 | 3455 | 2.440 |
Why?
|
Neoplastic Stem Cells | 24 | 2024 | 1351 | 2.230 |
Why?
|
Isocitrate Dehydrogenase | 15 | 2024 | 938 | 1.660 |
Why?
|
Herpes Simplex | 6 | 2024 | 478 | 1.050 |
Why?
|
Xenograft Model Antitumor Assays | 30 | 2024 | 3605 | 1.010 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 4 | 2020 | 83 | 0.990 |
Why?
|
Tumor Microenvironment | 14 | 2024 | 3878 | 0.940 |
Why?
|
NAD | 6 | 2021 | 614 | 0.930 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2019 | 988 | 0.920 |
Why?
|
Astrocytoma | 3 | 2024 | 775 | 0.900 |
Why?
|
Genetic Vectors | 23 | 2024 | 3396 | 0.870 |
Why?
|
Cyanides | 2 | 2020 | 82 | 0.860 |
Why?
|
Hyaluronoglucosaminidase | 2 | 2020 | 136 | 0.830 |
Why?
|
Herpesvirus 1, Human | 6 | 2023 | 753 | 0.830 |
Why?
|
Guanidines | 2 | 2020 | 194 | 0.820 |
Why?
|
Adenoviridae | 15 | 2024 | 1085 | 0.810 |
Why?
|
Cell Line, Tumor | 45 | 2024 | 16990 | 0.790 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2023 | 368 | 0.770 |
Why?
|
Mice | 87 | 2024 | 81539 | 0.770 |
Why?
|
Retinoblastoma Protein | 1 | 2023 | 672 | 0.690 |
Why?
|
Chromosomes, Artificial, Bacterial | 2 | 2019 | 123 | 0.660 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2022 | 5305 | 0.650 |
Why?
|
Animals | 107 | 2024 | 168475 | 0.650 |
Why?
|
Stereotaxic Techniques | 1 | 2021 | 555 | 0.640 |
Why?
|
DNA Mismatch Repair | 2 | 2020 | 428 | 0.630 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 544 | 0.620 |
Why?
|
Pericytes | 1 | 2020 | 293 | 0.600 |
Why?
|
Central Nervous System Neoplasms | 2 | 2023 | 916 | 0.580 |
Why?
|
Mice, SCID | 13 | 2020 | 2626 | 0.560 |
Why?
|
Endopeptidases | 1 | 2020 | 774 | 0.560 |
Why?
|
Mutation | 28 | 2024 | 30053 | 0.550 |
Why?
|
Specimen Handling | 1 | 2021 | 702 | 0.550 |
Why?
|
Tumor Cells, Cultured | 26 | 2020 | 6131 | 0.550 |
Why?
|
Molecular Targeted Therapy | 8 | 2024 | 2811 | 0.510 |
Why?
|
Neurofibromin 2 | 4 | 2024 | 271 | 0.500 |
Why?
|
Cytokines | 8 | 2022 | 7396 | 0.470 |
Why?
|
Piperazines | 6 | 2024 | 2523 | 0.460 |
Why?
|
Immunotherapy | 13 | 2024 | 4652 | 0.450 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 5 | 2024 | 899 | 0.430 |
Why?
|
Cell Cycle Proteins | 5 | 2019 | 3449 | 0.430 |
Why?
|
Indazoles | 1 | 2014 | 304 | 0.410 |
Why?
|
Disease Models, Animal | 23 | 2024 | 18255 | 0.410 |
Why?
|
Virus Replication | 14 | 2018 | 2435 | 0.400 |
Why?
|
Cell Proliferation | 18 | 2024 | 10451 | 0.390 |
Why?
|
Humans | 150 | 2024 | 761596 | 0.380 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 619 | 0.380 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2021 | 8554 | 0.380 |
Why?
|
Antineoplastic Agents, Alkylating | 5 | 2020 | 617 | 0.380 |
Why?
|
Apoptosis | 20 | 2019 | 9490 | 0.380 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2022 | 11742 | 0.360 |
Why?
|
Oligodendroglioma | 2 | 2024 | 279 | 0.350 |
Why?
|
Viruses | 3 | 2003 | 375 | 0.350 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1964 | 0.330 |
Why?
|
Proto-Oncogene Proteins c-akt | 9 | 2024 | 2457 | 0.330 |
Why?
|
Interleukin-12 | 5 | 2018 | 584 | 0.330 |
Why?
|
Immune Evasion | 3 | 2024 | 363 | 0.330 |
Why?
|
Membrane Proteins | 3 | 2020 | 7859 | 0.330 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 6 | 2018 | 192 | 0.320 |
Why?
|
Melanoma, Experimental | 6 | 2017 | 561 | 0.310 |
Why?
|
Ki-67 Antigen | 9 | 2022 | 629 | 0.310 |
Why?
|
Dacarbazine | 3 | 2017 | 559 | 0.310 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2019 | 2057 | 0.310 |
Why?
|
Imidazoles | 1 | 2014 | 1180 | 0.310 |
Why?
|
Mesenchymal Stem Cells | 5 | 2021 | 1642 | 0.300 |
Why?
|
Proto-Oncogene Proteins | 2 | 2018 | 4514 | 0.300 |
Why?
|
Mice, Nude | 13 | 2019 | 3614 | 0.300 |
Why?
|
Pyrimidines | 6 | 2022 | 3028 | 0.300 |
Why?
|
Neoplasm Recurrence, Local | 16 | 2024 | 9280 | 0.300 |
Why?
|
Neoplasms | 8 | 2024 | 22173 | 0.300 |
Why?
|
Complement Inactivator Proteins | 3 | 2004 | 74 | 0.290 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2048 | 0.290 |
Why?
|
RNA, Messenger | 9 | 2022 | 12794 | 0.280 |
Why?
|
Gene Deletion | 4 | 2024 | 2665 | 0.270 |
Why?
|
Protein Kinase Inhibitors | 9 | 2024 | 5672 | 0.270 |
Why?
|
Antineoplastic Agents | 10 | 2024 | 13642 | 0.260 |
Why?
|
Phthalazines | 2 | 2020 | 383 | 0.260 |
Why?
|
Pteridines | 2 | 2018 | 47 | 0.260 |
Why?
|
Enzyme Inhibitors | 6 | 2024 | 3713 | 0.250 |
Why?
|
Antibodies, Bispecific | 2 | 2019 | 196 | 0.240 |
Why?
|
Angiomyoma | 1 | 2024 | 11 | 0.240 |
Why?
|
Complement System Proteins | 4 | 2003 | 735 | 0.240 |
Why?
|
Cancer Vaccines | 3 | 2023 | 1051 | 0.240 |
Why?
|
Vero Cells | 5 | 2019 | 482 | 0.240 |
Why?
|
Transfection | 8 | 2019 | 5774 | 0.240 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2024 | 70 | 0.230 |
Why?
|
Signal Transduction | 15 | 2023 | 23447 | 0.230 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2024 | 28 | 0.230 |
Why?
|
Glucose | 1 | 2016 | 4347 | 0.230 |
Why?
|
Foramen Magnum | 1 | 2024 | 41 | 0.230 |
Why?
|
Neoplasm Proteins | 6 | 2018 | 3617 | 0.220 |
Why?
|
Viral Proteins | 3 | 2018 | 1804 | 0.220 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5314 | 0.220 |
Why?
|
Injections, Intralesional | 3 | 2020 | 280 | 0.220 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2024 | 698 | 0.220 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 5 | 2023 | 891 | 0.220 |
Why?
|
DNA Damage | 3 | 2020 | 2449 | 0.210 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2018 | 664 | 0.210 |
Why?
|
Methionine | 2 | 2024 | 572 | 0.200 |
Why?
|
Acetonitriles | 1 | 2022 | 54 | 0.200 |
Why?
|
Interleukin-2 | 4 | 2024 | 1889 | 0.200 |
Why?
|
Homozygote | 2 | 2024 | 1776 | 0.200 |
Why?
|
SOXB1 Transcription Factors | 2 | 2015 | 286 | 0.200 |
Why?
|
Genetic Engineering | 3 | 2018 | 933 | 0.200 |
Why?
|
Cyclophosphamide | 4 | 2004 | 2220 | 0.200 |
Why?
|
Female | 67 | 2024 | 392705 | 0.200 |
Why?
|
Cisterna Magna | 1 | 2021 | 39 | 0.200 |
Why?
|
Up-Regulation | 3 | 2020 | 4125 | 0.200 |
Why?
|
Retroviridae | 5 | 1997 | 850 | 0.200 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1263 | 0.190 |
Why?
|
Melanoma | 4 | 2024 | 5709 | 0.190 |
Why?
|
Acrylamides | 2 | 2020 | 260 | 0.190 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2024 | 350 | 0.190 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 84 | 0.180 |
Why?
|
Immunohistochemistry | 12 | 2019 | 11076 | 0.180 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2024 | 561 | 0.180 |
Why?
|
Antigens, CD | 4 | 2021 | 4001 | 0.180 |
Why?
|
Aminopyridines | 1 | 2024 | 573 | 0.180 |
Why?
|
Hexokinase | 1 | 2020 | 124 | 0.170 |
Why?
|
Genetic Heterogeneity | 2 | 2021 | 732 | 0.170 |
Why?
|
Hexanones | 1 | 2019 | 5 | 0.170 |
Why?
|
T-Lymphocytes | 5 | 2024 | 10194 | 0.170 |
Why?
|
Spinal Cord Neoplasms | 1 | 2022 | 263 | 0.170 |
Why?
|
Glycoside Hydrolases | 1 | 2020 | 135 | 0.170 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2020 | 184 | 0.170 |
Why?
|
IMP Dehydrogenase | 1 | 2019 | 33 | 0.170 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2024 | 2057 | 0.170 |
Why?
|
Transcription Factor RelA | 1 | 2020 | 254 | 0.170 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2020 | 455 | 0.160 |
Why?
|
Hyaluronic Acid | 2 | 2020 | 483 | 0.160 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2022 | 424 | 0.160 |
Why?
|
Sequence Deletion | 1 | 2023 | 1494 | 0.160 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2019 | 88 | 0.160 |
Why?
|
Immunity, Innate | 3 | 2024 | 3066 | 0.160 |
Why?
|
Benzimidazoles | 1 | 2024 | 858 | 0.160 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2019 | 2872 | 0.160 |
Why?
|
Pyridines | 3 | 2024 | 2875 | 0.160 |
Why?
|
Neoplasm Transplantation | 7 | 2017 | 2016 | 0.160 |
Why?
|
Tachycardia | 1 | 2001 | 600 | 0.160 |
Why?
|
Cell Differentiation | 6 | 2024 | 11530 | 0.160 |
Why?
|
Lung Neoplasms | 3 | 2022 | 13381 | 0.150 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2019 | 146 | 0.150 |
Why?
|
Sirtuins | 1 | 2021 | 320 | 0.150 |
Why?
|
Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2018 | 58 | 0.150 |
Why?
|
Permeability | 1 | 2020 | 723 | 0.150 |
Why?
|
Neural Stem Cells | 4 | 2012 | 888 | 0.150 |
Why?
|
Gene Silencing | 3 | 2021 | 1509 | 0.140 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2022 | 774 | 0.140 |
Why?
|
Dystrophin | 1 | 2018 | 283 | 0.140 |
Why?
|
DNA-Binding Proteins | 4 | 2020 | 9610 | 0.140 |
Why?
|
Quinazolinones | 1 | 2019 | 221 | 0.140 |
Why?
|
Interleukin-4 | 3 | 2006 | 1149 | 0.140 |
Why?
|
Hydroxyurea | 1 | 2018 | 284 | 0.140 |
Why?
|
Delayed-Action Preparations | 1 | 2020 | 962 | 0.140 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2017 | 129 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2022 | 2827 | 0.140 |
Why?
|
Oxazines | 1 | 2019 | 350 | 0.140 |
Why?
|
Cell Movement | 6 | 2020 | 5205 | 0.140 |
Why?
|
Autophagy | 3 | 2020 | 1327 | 0.130 |
Why?
|
Gene Transfer Techniques | 5 | 2002 | 1206 | 0.130 |
Why?
|
Rad51 Recombinase | 1 | 2017 | 189 | 0.130 |
Why?
|
Amino Acid Transport System y+ | 1 | 2016 | 37 | 0.130 |
Why?
|
Glycolysis | 2 | 2020 | 835 | 0.130 |
Why?
|
Glutarates | 3 | 2024 | 243 | 0.130 |
Why?
|
RNA, Small Interfering | 5 | 2019 | 3430 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2016 | 3492 | 0.130 |
Why?
|
Drug Carriers | 1 | 2020 | 706 | 0.130 |
Why?
|
Radiation Tolerance | 2 | 2016 | 478 | 0.130 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2019 | 655 | 0.130 |
Why?
|
Transduction, Genetic | 5 | 2009 | 903 | 0.130 |
Why?
|
Radiobiology | 1 | 2016 | 90 | 0.130 |
Why?
|
Cell Cycle | 7 | 2019 | 2932 | 0.130 |
Why?
|
Cell Hypoxia | 2 | 2015 | 657 | 0.130 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2016 | 149 | 0.120 |
Why?
|
Neoplasm Invasiveness | 4 | 2012 | 3597 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2019 | 2865 | 0.120 |
Why?
|
Transgenes | 1 | 2019 | 1010 | 0.120 |
Why?
|
Nuclear Proteins | 6 | 2016 | 5799 | 0.120 |
Why?
|
Stromal Cells | 1 | 2020 | 1330 | 0.120 |
Why?
|
Mice, Inbred C57BL | 13 | 2024 | 22174 | 0.120 |
Why?
|
Extracellular Matrix | 2 | 2020 | 1726 | 0.120 |
Why?
|
Blotting, Western | 4 | 2017 | 5035 | 0.120 |
Why?
|
Macrophages | 3 | 2020 | 5767 | 0.120 |
Why?
|
Nucleoside Deaminases | 3 | 2002 | 58 | 0.120 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 1993 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2020 | 805 | 0.120 |
Why?
|
HEK293 Cells | 4 | 2017 | 4281 | 0.120 |
Why?
|
DNA Repair | 3 | 2020 | 2046 | 0.120 |
Why?
|
Neurodegenerative Diseases | 1 | 2024 | 1088 | 0.120 |
Why?
|
Neoplasms, Experimental | 2 | 2019 | 1229 | 0.120 |
Why?
|
Antibodies, Neoplasm | 1 | 2016 | 281 | 0.120 |
Why?
|
Introns | 1 | 2017 | 981 | 0.120 |
Why?
|
Telomerase | 4 | 2024 | 745 | 0.120 |
Why?
|
Survival Analysis | 7 | 2020 | 10090 | 0.120 |
Why?
|
Piperidines | 2 | 2020 | 1656 | 0.120 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 1745 | 0.120 |
Why?
|
Neovascularization, Pathologic | 4 | 2018 | 2645 | 0.120 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2024 | 44 | 0.120 |
Why?
|
Glycoproteins | 2 | 2013 | 2203 | 0.120 |
Why?
|
Digoxin | 1 | 2015 | 246 | 0.110 |
Why?
|
Antibodies, Neutralizing | 1 | 2024 | 1943 | 0.110 |
Why?
|
DNA Replication | 2 | 2018 | 1418 | 0.110 |
Why?
|
Random Allocation | 2 | 2017 | 2395 | 0.110 |
Why?
|
Angiostatins | 1 | 2013 | 64 | 0.110 |
Why?
|
Vaccines, Synthetic | 1 | 1996 | 616 | 0.110 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 353 | 0.110 |
Why?
|
Vesicular Transport Proteins | 1 | 2016 | 376 | 0.110 |
Why?
|
Polymers | 1 | 2020 | 1616 | 0.110 |
Why?
|
Mitosis | 1 | 2018 | 1188 | 0.110 |
Why?
|
Blood-Brain Barrier | 1 | 2020 | 1027 | 0.110 |
Why?
|
Transcription Factors | 6 | 2020 | 12130 | 0.110 |
Why?
|
Biological Therapy | 1 | 2014 | 141 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1158 | 0.110 |
Why?
|
DNA, Viral | 2 | 2017 | 2202 | 0.110 |
Why?
|
Rats, Nude | 5 | 2004 | 105 | 0.100 |
Why?
|
Genotype | 3 | 2018 | 12990 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1334 | 0.100 |
Why?
|
World Health Organization | 3 | 2023 | 1322 | 0.100 |
Why?
|
Prognosis | 11 | 2024 | 29629 | 0.100 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 634 | 0.100 |
Why?
|
Sulfones | 1 | 2015 | 448 | 0.100 |
Why?
|
Oligonucleotides | 1 | 2015 | 582 | 0.100 |
Why?
|
Gene Amplification | 1 | 2016 | 1089 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2016 | 726 | 0.090 |
Why?
|
Single-Cell Analysis | 5 | 2024 | 2451 | 0.090 |
Why?
|
Lymphoma | 1 | 2020 | 1901 | 0.090 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2011 | 70 | 0.090 |
Why?
|
Neoplasm Metastasis | 3 | 2018 | 4915 | 0.090 |
Why?
|
Down-Regulation | 1 | 2018 | 2919 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2024 | 4580 | 0.090 |
Why?
|
Dilazep | 1 | 2010 | 4 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2020 | 2917 | 0.090 |
Why?
|
Cytotoxicity, Immunologic | 3 | 2021 | 1351 | 0.090 |
Why?
|
Cell Division | 5 | 2011 | 4465 | 0.090 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2010 | 17 | 0.090 |
Why?
|
Cohort Studies | 6 | 2022 | 41495 | 0.090 |
Why?
|
Receptors, Notch | 3 | 2022 | 744 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1136 | 0.090 |
Why?
|
MicroRNAs | 2 | 2018 | 3816 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2021 | 499 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6484 | 0.090 |
Why?
|
Dipyridamole | 1 | 2010 | 140 | 0.090 |
Why?
|
RNA Interference | 2 | 2016 | 2832 | 0.090 |
Why?
|
Etoposide | 1 | 2011 | 634 | 0.090 |
Why?
|
Tumor Escape | 2 | 2024 | 370 | 0.080 |
Why?
|
Stress, Physiological | 1 | 2017 | 1403 | 0.080 |
Why?
|
Middle Aged | 24 | 2024 | 220921 | 0.080 |
Why?
|
Furans | 1 | 2010 | 202 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2014 | 738 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2013 | 718 | 0.080 |
Why?
|
Radiotherapy Dosage | 1 | 2016 | 2898 | 0.080 |
Why?
|
Pyrazines | 1 | 2015 | 1202 | 0.080 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2012 | 495 | 0.080 |
Why?
|
Telomere | 1 | 2015 | 943 | 0.080 |
Why?
|
alpha-Fetoproteins | 3 | 2002 | 223 | 0.080 |
Why?
|
Trigeminal Neuralgia | 1 | 2009 | 107 | 0.080 |
Why?
|
Oncogenes | 1 | 2014 | 1222 | 0.080 |
Why?
|
Combined Modality Therapy | 6 | 2020 | 8527 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 4 | 2020 | 2805 | 0.070 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2014 | 2510 | 0.070 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4369 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1459 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2014 | 946 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4878 | 0.070 |
Why?
|
Young Adult | 10 | 2024 | 59260 | 0.070 |
Why?
|
Aged | 19 | 2024 | 169310 | 0.070 |
Why?
|
Cell Lineage | 3 | 2024 | 2557 | 0.070 |
Why?
|
Drug Delivery Systems | 2 | 2018 | 2226 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2024 | 80647 | 0.070 |
Why?
|
Male | 30 | 2024 | 360846 | 0.070 |
Why?
|
Histones | 3 | 2023 | 2580 | 0.070 |
Why?
|
Adult | 21 | 2024 | 221210 | 0.070 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2022 | 5672 | 0.070 |
Why?
|
Cerebellopontine Angle | 1 | 2006 | 53 | 0.070 |
Why?
|
Capsid Proteins | 1 | 2009 | 468 | 0.070 |
Why?
|
Histone Demethylases | 2 | 2020 | 323 | 0.060 |
Why?
|
Polymerase Chain Reaction | 6 | 2011 | 6075 | 0.060 |
Why?
|
Epidermal Cyst | 1 | 2006 | 64 | 0.060 |
Why?
|
Lac Operon | 4 | 2002 | 237 | 0.060 |
Why?
|
Transplantation, Heterologous | 2 | 2011 | 2386 | 0.060 |
Why?
|
Rats, Inbred F344 | 2 | 2004 | 826 | 0.060 |
Why?
|
Carcinoembryonic Antigen | 2 | 1996 | 337 | 0.060 |
Why?
|
Child | 7 | 2023 | 80158 | 0.060 |
Why?
|
Phenotype | 2 | 2014 | 16592 | 0.060 |
Why?
|
Receptors, Progesterone | 2 | 2022 | 1129 | 0.060 |
Why?
|
Stem Cells | 2 | 2023 | 3524 | 0.060 |
Why?
|
Dependovirus | 1 | 2009 | 718 | 0.060 |
Why?
|
Bystander Effect | 2 | 2018 | 90 | 0.060 |
Why?
|
RNA Polymerase III | 1 | 2024 | 58 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2021 | 1092 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2014 | 6815 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2019 | 1827 | 0.050 |
Why?
|
Callithrix | 1 | 2003 | 95 | 0.050 |
Why?
|
Thymidine Kinase | 3 | 2004 | 286 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2019 | 8002 | 0.050 |
Why?
|
Ganciclovir | 3 | 2004 | 252 | 0.050 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2003 | 65 | 0.050 |
Why?
|
Connexins | 1 | 2024 | 352 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2002 | 2297 | 0.050 |
Why?
|
Carbon Radioisotopes | 1 | 2024 | 561 | 0.050 |
Why?
|
Herpesvirus 2, Human | 1 | 2024 | 191 | 0.050 |
Why?
|
Atrial Fibrillation | 1 | 2001 | 5127 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2024 | 244 | 0.050 |
Why?
|
Adolescent | 10 | 2024 | 88326 | 0.050 |
Why?
|
Peptides | 2 | 2013 | 4358 | 0.050 |
Why?
|
Rats | 6 | 2004 | 23741 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2019 | 21019 | 0.050 |
Why?
|
Oncostatin M Receptor beta Subunit | 1 | 2021 | 4 | 0.050 |
Why?
|
Radiotherapy | 2 | 2010 | 1498 | 0.050 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2021 | 30 | 0.050 |
Why?
|
Astrocytes | 2 | 2024 | 1346 | 0.050 |
Why?
|
Methylation | 2 | 2016 | 1084 | 0.050 |
Why?
|
RNA | 2 | 2024 | 2725 | 0.050 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 615 | 0.050 |
Why?
|
Cytokine Receptor gp130 | 1 | 2021 | 66 | 0.050 |
Why?
|
Ligands | 2 | 2018 | 3272 | 0.050 |
Why?
|
Oncostatin M | 1 | 2021 | 42 | 0.050 |
Why?
|
Gene Expression | 3 | 2014 | 7581 | 0.050 |
Why?
|
Cholinergic Agonists | 1 | 2001 | 75 | 0.050 |
Why?
|
Gene Expression Profiling | 4 | 2021 | 9420 | 0.050 |
Why?
|
Base Sequence | 4 | 2016 | 12441 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4576 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2003 | 412 | 0.050 |
Why?
|
Receptor, Notch1 | 1 | 2024 | 496 | 0.050 |
Why?
|
Cerebellar Neoplasms | 1 | 2006 | 586 | 0.050 |
Why?
|
Survival Rate | 5 | 2020 | 12723 | 0.050 |
Why?
|
Models, Animal | 2 | 2006 | 2112 | 0.050 |
Why?
|
Carbachol | 1 | 2001 | 223 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2024 | 504 | 0.050 |
Why?
|
Disease Progression | 6 | 2020 | 13510 | 0.050 |
Why?
|
Interferon-gamma | 2 | 2022 | 3162 | 0.050 |
Why?
|
Positron-Emission Tomography | 3 | 2024 | 6484 | 0.050 |
Why?
|
DNA Transposable Elements | 1 | 2024 | 755 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2001 | 255 | 0.040 |
Why?
|
Complement Activation | 1 | 2002 | 445 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 2 | 2021 | 1802 | 0.040 |
Why?
|
Enzyme Activation | 3 | 2015 | 3597 | 0.040 |
Why?
|
Killer Cells, Natural | 2 | 2021 | 2201 | 0.040 |
Why?
|
Sirtuin 1 | 1 | 2021 | 246 | 0.040 |
Why?
|
Thiadiazoles | 1 | 2019 | 63 | 0.040 |
Why?
|
HeLa Cells | 4 | 2015 | 3094 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2022 | 641 | 0.040 |
Why?
|
Caspases | 2 | 2018 | 879 | 0.040 |
Why?
|
Viral Matrix Proteins | 1 | 2020 | 196 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 1405 | 0.040 |
Why?
|
Benzodiazepinones | 1 | 2018 | 50 | 0.040 |
Why?
|
Xenopus Proteins | 1 | 2002 | 434 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
Cell Nucleolus | 1 | 2019 | 156 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2021 | 18966 | 0.040 |
Why?
|
Genetic Variation | 1 | 2014 | 6567 | 0.040 |
Why?
|
Postoperative Period | 1 | 2023 | 1814 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2002 | 451 | 0.040 |
Why?
|
Cell Survival | 3 | 2017 | 5791 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2015 | 1612 | 0.040 |
Why?
|
Brain | 8 | 2023 | 27121 | 0.040 |
Why?
|
Receptors, Death Domain | 1 | 2018 | 31 | 0.040 |
Why?
|
Empyema, Subdural | 1 | 1998 | 12 | 0.040 |
Why?
|
Promoter Regions, Genetic | 3 | 2020 | 5790 | 0.040 |
Why?
|
Liver Neoplasms | 3 | 2002 | 4317 | 0.040 |
Why?
|
Hemangiopericytoma | 1 | 1998 | 71 | 0.040 |
Why?
|
Genes, Transgenic, Suicide | 1 | 2018 | 34 | 0.040 |
Why?
|
RNA, Ribosomal | 1 | 2019 | 227 | 0.040 |
Why?
|
Immunization | 1 | 2023 | 1227 | 0.040 |
Why?
|
Progesterone | 1 | 2022 | 742 | 0.040 |
Why?
|
Immunoconjugates | 2 | 2018 | 953 | 0.040 |
Why?
|
Cardiotonic Agents | 1 | 2001 | 539 | 0.040 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2018 | 110 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2020 | 58984 | 0.040 |
Why?
|
Protein Stability | 1 | 2019 | 578 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2017 | 2021 | 0.040 |
Why?
|
Species Specificity | 1 | 2002 | 2414 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 585 | 0.040 |
Why?
|
DNA Methylation | 2 | 2024 | 4399 | 0.040 |
Why?
|
Brain Abscess | 1 | 1998 | 120 | 0.040 |
Why?
|
Genes, gag | 1 | 1997 | 55 | 0.040 |
Why?
|
Tumor Stem Cell Assay | 1 | 2017 | 115 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2022 | 1784 | 0.040 |
Why?
|
Uterine Prolapse | 1 | 1997 | 68 | 0.040 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2001 | 866 | 0.040 |
Why?
|
Ligaments | 1 | 1997 | 127 | 0.040 |
Why?
|
Pulmonary Fibrosis | 1 | 2021 | 505 | 0.030 |
Why?
|
Immunomodulation | 1 | 2021 | 549 | 0.030 |
Why?
|
Cadherins | 1 | 2021 | 903 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 871 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 695 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3801 | 0.030 |
Why?
|
Cell Line | 3 | 2017 | 15601 | 0.030 |
Why?
|
Flow Cytometry | 4 | 2013 | 5870 | 0.030 |
Why?
|
Prodrugs | 1 | 2018 | 261 | 0.030 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2020 | 587 | 0.030 |
Why?
|
Defective Viruses | 1 | 1996 | 89 | 0.030 |
Why?
|
Pentosyltransferases | 1 | 2015 | 62 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5821 | 0.030 |
Why?
|
Autonomic Nervous System | 1 | 2001 | 703 | 0.030 |
Why?
|
Stomach Neoplasms | 2 | 1996 | 1459 | 0.030 |
Why?
|
Picibanil | 1 | 1995 | 10 | 0.030 |
Why?
|
Elastin | 1 | 1997 | 298 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 352 | 0.030 |
Why?
|
Sulfasalazine | 1 | 2016 | 84 | 0.030 |
Why?
|
Drug Repositioning | 1 | 2018 | 233 | 0.030 |
Why?
|
Central Nervous System | 1 | 2003 | 1336 | 0.030 |
Why?
|
Immunoenzyme Techniques | 2 | 1996 | 1704 | 0.030 |
Why?
|
Cystine | 1 | 2016 | 94 | 0.030 |
Why?
|
NF-kappa B | 2 | 2020 | 2490 | 0.030 |
Why?
|
Chromatin | 2 | 2021 | 2961 | 0.030 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 171 | 0.030 |
Why?
|
DNA Primers | 2 | 1997 | 2820 | 0.030 |
Why?
|
Infant | 4 | 2023 | 36193 | 0.030 |
Why?
|
Hepatocyte Growth Factor | 1 | 1997 | 271 | 0.030 |
Why?
|
Protein Binding | 2 | 2019 | 9353 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 2065 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2024 | 4111 | 0.030 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2015 | 20 | 0.030 |
Why?
|
Phosphorylation | 2 | 2019 | 8321 | 0.030 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2017 | 426 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1997 | 779 | 0.030 |
Why?
|
Immunoblotting | 2 | 2011 | 1646 | 0.030 |
Why?
|
Antigens, Surface | 1 | 2019 | 1606 | 0.030 |
Why?
|
Growth Substances | 1 | 1997 | 768 | 0.030 |
Why?
|
Replication Protein A | 1 | 2015 | 53 | 0.030 |
Why?
|
Child, Preschool | 4 | 2023 | 42232 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3810 | 0.030 |
Why?
|
Recombinant Proteins | 4 | 1997 | 6534 | 0.030 |
Why?
|
Cytosine Deaminase | 3 | 2002 | 66 | 0.030 |
Why?
|
3T3 Cells | 1 | 1996 | 1085 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2024 | 64685 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1055 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 330 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 945 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 190 | 0.030 |
Why?
|
Genetic Markers | 2 | 1997 | 2601 | 0.030 |
Why?
|
Biomimetic Materials | 1 | 2014 | 172 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 84 | 0.030 |
Why?
|
Immunosuppressive Agents | 2 | 2003 | 4176 | 0.030 |
Why?
|
Cell Death | 1 | 2018 | 1679 | 0.030 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 1995 | 410 | 0.030 |
Why?
|
RNA Splicing | 1 | 2017 | 918 | 0.030 |
Why?
|
Transplantation, Isogeneic | 1 | 2012 | 248 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2002 | 2418 | 0.030 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 2012 | 151 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 598 | 0.030 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1996 | 646 | 0.020 |
Why?
|
Lysine | 1 | 2016 | 993 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 1996 | 1784 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2001 | 2448 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2002 | 2244 | 0.020 |
Why?
|
Genome, Viral | 1 | 1995 | 667 | 0.020 |
Why?
|
Gene Order | 1 | 2012 | 169 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 934 | 0.020 |
Why?
|
Receptors, Virus | 1 | 1995 | 640 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2822 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2012 | 384 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2024 | 3639 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 2011 | 246 | 0.020 |
Why?
|
Th1 Cells | 1 | 1996 | 1036 | 0.020 |
Why?
|
Carotid Arteries | 1 | 1995 | 941 | 0.020 |
Why?
|
RNA, Untranslated | 1 | 2015 | 459 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2024 | 12973 | 0.020 |
Why?
|
DNA Modification Methylases | 1 | 2011 | 210 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2012 | 181 | 0.020 |
Why?
|
Tissue Distribution | 2 | 2007 | 2264 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2012 | 670 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 1668 | 0.020 |
Why?
|
Hemodynamics | 1 | 2001 | 4160 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7213 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2006 | 4024 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2016 | 1176 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2004 | 4352 | 0.020 |
Why?
|
Ribonucleotide Reductases | 1 | 2010 | 76 | 0.020 |
Why?
|
Flucytosine | 2 | 2002 | 33 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1363 | 0.020 |
Why?
|
DNA Shuffling | 1 | 2009 | 5 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 1997 | 17635 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2011 | 346 | 0.020 |
Why?
|
Combinatorial Chemistry Techniques | 1 | 2010 | 135 | 0.020 |
Why?
|
Protein Kinases | 1 | 2016 | 1608 | 0.020 |
Why?
|
DNA Helicases | 1 | 2015 | 851 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1898 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1995 | 1492 | 0.020 |
Why?
|
Disease Management | 1 | 2020 | 2508 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2015 | 897 | 0.020 |
Why?
|
Mice, Inbred BALB C | 3 | 2006 | 6214 | 0.020 |
Why?
|
Transcription, Genetic | 3 | 2016 | 7593 | 0.020 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1996 | 954 | 0.020 |
Why?
|
Radiosurgery | 2 | 2010 | 1342 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9542 | 0.020 |
Why?
|
Immunotherapy, Adoptive | 2 | 1996 | 1469 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1362 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2139 | 0.020 |
Why?
|
Antioxidants | 1 | 2016 | 1668 | 0.020 |
Why?
|
Camptothecin | 1 | 2011 | 591 | 0.020 |
Why?
|
Electrocardiography | 1 | 2001 | 6377 | 0.020 |
Why?
|
Organ Culture Techniques | 1 | 2010 | 795 | 0.020 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2011 | 621 | 0.020 |
Why?
|
Epigenomics | 1 | 2013 | 943 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2010 | 11122 | 0.020 |
Why?
|
RNA, Viral | 1 | 1995 | 2846 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2013 | 1475 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1341 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3080 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10554 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2012 | 1136 | 0.020 |
Why?
|
Gene Library | 1 | 2009 | 1059 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1892 | 0.020 |
Why?
|
Cell Membrane | 1 | 2016 | 3687 | 0.020 |
Why?
|
Chemokine CCL21 | 1 | 2006 | 50 | 0.020 |
Why?
|
Genes, p53 | 2 | 1999 | 712 | 0.020 |
Why?
|
Metabolomics | 1 | 2015 | 1659 | 0.020 |
Why?
|
Adenine | 1 | 2012 | 987 | 0.020 |
Why?
|
Graft Rejection | 2 | 1996 | 4446 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1651 | 0.020 |
Why?
|
Time Factors | 4 | 2015 | 39969 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2012 | 1486 | 0.020 |
Why?
|
Caspase 3 | 1 | 2007 | 731 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2012 | 2645 | 0.020 |
Why?
|
Chemokines, CC | 1 | 2006 | 283 | 0.020 |
Why?
|
Blood Vessels | 1 | 2010 | 1113 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2015 | 2882 | 0.010 |
Why?
|
CD40 Ligand | 1 | 2006 | 522 | 0.010 |
Why?
|
Mice, Inbred DBA | 2 | 1995 | 621 | 0.010 |
Why?
|
Lung | 1 | 2021 | 10002 | 0.010 |
Why?
|
Diuretics, Osmotic | 1 | 2002 | 33 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 1996 | 9177 | 0.010 |
Why?
|
Genome, Human | 1 | 2015 | 4425 | 0.010 |
Why?
|
Heparin | 1 | 2009 | 1634 | 0.010 |
Why?
|
Infusions, Intra-Arterial | 1 | 2002 | 221 | 0.010 |
Why?
|
Mannitol | 1 | 2002 | 180 | 0.010 |
Why?
|
Genes, erbB-1 | 1 | 2002 | 162 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4415 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2004 | 594 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2009 | 1250 | 0.010 |
Why?
|
Gadolinium | 1 | 2006 | 960 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36426 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8656 | 0.010 |
Why?
|
Plasmids | 1 | 2006 | 2269 | 0.010 |
Why?
|
Interleukin-8 | 1 | 2004 | 696 | 0.010 |
Why?
|
Elapid Venoms | 1 | 2000 | 40 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26202 | 0.010 |
Why?
|
Interleukin-1 | 1 | 2004 | 1248 | 0.010 |
Why?
|
Patch-Clamp Techniques | 1 | 2002 | 927 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 11904 | 0.010 |
Why?
|
Electrophysiology | 1 | 2002 | 1262 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2002 | 1749 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6766 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39106 | 0.010 |
Why?
|
Virus Activation | 1 | 2000 | 322 | 0.010 |
Why?
|
Cisplatin | 1 | 2004 | 1652 | 0.010 |
Why?
|
Potassium | 1 | 2002 | 1311 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2003 | 1115 | 0.010 |
Why?
|
Thymidine | 1 | 1997 | 299 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2001 | 1900 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1968 | 0.010 |
Why?
|
Vascular Neoplasms | 1 | 1998 | 166 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1787 | 0.010 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1996 | 221 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1996 | 5821 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1996 | 158 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2005 | 15266 | 0.010 |
Why?
|
United States | 1 | 2024 | 72340 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2011 | 14417 | 0.010 |
Why?
|
Hypersensitivity, Delayed | 1 | 1996 | 490 | 0.010 |
Why?
|
Image Enhancement | 1 | 2006 | 2884 | 0.010 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 1995 | 221 | 0.010 |
Why?
|
Genes, Viral | 1 | 1996 | 649 | 0.010 |
Why?
|
Heterozygote | 1 | 2002 | 2787 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 1998 | 20568 | 0.010 |
Why?
|
Antibody Formation | 1 | 1999 | 1395 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1999 | 1526 | 0.010 |
Why?
|
Action Potentials | 1 | 2002 | 1834 | 0.010 |
Why?
|
Interleukin-7 | 1 | 1994 | 143 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2004 | 3208 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 1997 | 571 | 0.010 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1995 | 439 | 0.010 |
Why?
|
Myocytes, Cardiac | 1 | 2002 | 1668 | 0.010 |
Why?
|
Tachycardia, Ventricular | 1 | 2002 | 1304 | 0.010 |
Why?
|
Exons | 1 | 1999 | 2391 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1996 | 1126 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1996 | 1529 | 0.010 |
Why?
|
Spinal Neoplasms | 1 | 1998 | 716 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 1997 | 1745 | 0.010 |
Why?
|
Fluorouracil | 1 | 1996 | 1642 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2004 | 3060 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 74213 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2004 | 5112 | 0.010 |
Why?
|
Brain Edema | 1 | 1995 | 604 | 0.010 |
Why?
|
Catheterization | 1 | 1995 | 1428 | 0.010 |
Why?
|
Drug Resistance | 1 | 1996 | 1596 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 1997 | 2112 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1996 | 1349 | 0.010 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1997 | 1626 | 0.010 |
Why?
|
Rabbits | 1 | 1995 | 4772 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4243 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2503 | 0.000 |
Why?
|
Antibodies, Viral | 1 | 1999 | 3156 | 0.000 |
Why?
|
Kidney | 1 | 2003 | 7048 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1996 | 4807 | 0.000 |
Why?
|
Liver | 1 | 2003 | 7528 | 0.000 |
Why?
|
Receptors, Estrogen | 1 | 1995 | 2209 | 0.000 |
Why?
|
Neurosurgical Procedures | 1 | 1998 | 2072 | 0.000 |
Why?
|
Uterine Neoplasms | 1 | 1996 | 1420 | 0.000 |
Why?
|
Fibroblasts | 1 | 1997 | 4142 | 0.000 |
Why?
|
Vaccines | 1 | 1995 | 844 | 0.000 |
Why?
|
Graft Survival | 1 | 1996 | 3820 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1996 | 13446 | 0.000 |
Why?
|
Decision Making | 1 | 1998 | 3929 | 0.000 |
Why?
|
Vaccination | 1 | 1995 | 3384 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1998 | 7406 | 0.000 |
Why?
|
Pancreatic Neoplasms | 1 | 1996 | 5368 | 0.000 |
Why?
|
Colorectal Neoplasms | 1 | 1996 | 6938 | 0.000 |
Why?
|